Literature DB >> 2438637

Mucolipidosis type IV: clinical spectrum and natural history.

N Amir, J Zlotogora, G Bach.   

Abstract

The clinical spectrum and developmental features of mucolipidosis type IV, a recessive lysosomal storage disorder, are presented. The evaluation was based on information from the clinical charts and information obtained from the families of 20 patients between the ages of 2 to 17 years. The clinical manifestations of the disease, profound psychomotor retardation and visual impairment, appear during the first year of life. Definitive diagnosis is made by electron microscopy which reveals storage organelles typical of the mucolipidoses. This study details, for the first time, the heterogeneity of the ophthalmologic features, specifically as pertains to the age of onset, degree and clinical course of the corneal opacities, and the retinal involvement. Although the top developmental level was found to be 12 to 15 months in language and motor function, the course of the disease is protracted for some children, who show only a slight improvement, and others, little if any deterioration despite the early infantile onset of the disease. This presentation provides guidelines for the clinical diagnosis of mucolipidosis type IV.

Entities:  

Mesh:

Year:  1987        PMID: 2438637

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  45 in total

1.  Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.

Authors:  Lisa Edelmann; Jianli Dong; Robert J Desnick; Ruth Kornreich
Journal:  Am J Hum Genet       Date:  2002-02-13       Impact factor: 11.025

2.  G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts.

Authors:  S Raghavan; E Leshinsky; E H Kolodny
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Mucolipidosis type IV: abnormal transport of lipids to lysosomes.

Authors:  R Bargal; G Bach
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

4.  The calcium channel mucolipin-3 is a novel regulator of trafficking along the endosomal pathway.

Authors:  Jose A Martina; Benjamin Lelouvier; Rosa Puertollano
Journal:  Traffic       Date:  2009-04-29       Impact factor: 6.215

Review 5.  TRPMLs: in sickness and in health.

Authors:  Rosa Puertollano; Kirill Kiselyov
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

6.  Cognitive Development in a Young Child with Mucolipidosis Type IV: A Case Report.

Authors:  Evelyn L Fisher; Rose A Sevcik; MaryAnn Romski
Journal:  JIMD Rep       Date:  2017-01-03

Review 7.  Role of TRP channels in the regulation of the endosomal pathway.

Authors:  Ken Abe; Rosa Puertollano
Journal:  Physiology (Bethesda)       Date:  2011-02

8.  The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types.

Authors:  Bradley M Hersh; Erika Hartwieg; H Robert Horvitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 9.  Invertebrate TRP proteins as functional models for mammalian channels.

Authors:  Joris Vriens; Grzegorz Owsianik; Thomas Voets; Guy Droogmans; Bernd Nilius
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

Review 10.  Mucolipin 1: endocytosis and cation channel--a review.

Authors:  Gideon Bach
Journal:  Pflugers Arch       Date:  2004-11-27       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.